Seroquel and Poor venous access - a phase IV clinical study of FDA data

Summary:

Poor venous access is reported as a side effect among people who take Seroquel (quetiapine fumarate), especially for people who are female, 30-39 old, also take Inflectra, and have Crohn's disease.

The phase IV clinical study analyzes which people have Poor venous access when taking Seroquel. It is created by eHealthMe based on reports of 113,615 people who have side effects when taking Seroquel from the FDA, and is updated regularly.

What is Seroquel?

Seroquel has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. eHealthMe is studying from 120,285 Seroquel users. Check the latest studies of Seroquel.

What is Poor venous access?

Poor venous access is found to be associated with 676 drugs and 480 conditions by eHealthMe. Check the latest studies of Poor venous access.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

113,615 people reported to have side effects when taking Seroquel.
Among them, 62 people (0.05%) have Poor venous access.

Could Seroquel cause Poor venous access?

Among these 62 people:

What is the gender of people who have Poor venous access when taking Seroquel? *

female: 94.44 %
male: 5.56 %

What is the age of people who have Poor venous access when taking Seroquel? *

What are other drugs people take besides Seroquel? *

What are other side effects people have besides Poor venous access? *

Diarrhea: 29 people, 46.77%
Dehydration (dryness resulting from the removal of water): 27 people, 43.55%
Weakness: 24 people, 38.71%
Malaise (a feeling of general discomfort or uneasiness): 24 people, 38.71%
Fatigue (feeling of tiredness): 19 people, 30.65%
Oropharyngeal Pain: 18 people, 29.03%
Nausea (feeling of having an urge to vomit): 17 people, 27.42%
Pain: 16 people, 25.81%
Weight Increased: 16 people, 25.81%
Joint Pain: 15 people, 24.19%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 33 people, 53.23%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 8 people, 12.90%
Otitis (ear infection): 8 people, 12.90%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 9.68%
Stress And Anxiety: 5 people, 8.06%
Birth Control: 5 people, 8.06%
Personality Disorder: 5 people, 8.06%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 6.45%
Post-Traumatic Stress Disorder: 3 people, 4.84%
Immunoglobulins Decreased: 3 people, 4.84%

* Approximation only. Some reports may have incomplete information.

Do you take Seroquel and have Poor venous access?

- Check whether Poor venous access is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seroquel:

Seroquel (120,285 reports)

Browse all side effects of Seroquel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor venous access:

Poor venous access (676 drugs)

Browse all the conditions that are associated with Poor venous access:

Poor venous access (480 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on quetiapine fumarate (the active ingredients of Seroquel) and Seroquel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.